Anne T. Mancino

University of Arkansas for Medical Sciences

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Ronda Henry‐Tillman

University of Arkansas for Medical Sciences

V. Suzanne Klimberg

The University of Texas Medical Branch at Galveston

Rena Kass

Penn State Milton S. Hershey Medical Center

Gabriele Alessandrini

Istituti di Ricovero e Cura a Carattere Scientifico

Nicoletta Cassano

Prysmian Group (United States)

P. Ligori

University of Bari Aldo Moro

Kent C. Westbrook

University of Arkansas for Medical Sciences

Dario Fai

University of Salento

Maurizio Sodo

Federico II University Hospital

Soheila Korourian

University of Arkansas for Medical Sciences

Cooperative Institutions

University of Arkansas for Medical Sciences

The University of Texas MD Anderson Cancer Center

Central Arkansas Veterans Healthcare System

University of Bari Aldo Moro

Johns Hopkins University

Memorial Sloan Kettering Cancer Center

Northwestern University

Florida College

Winthrop Rockefeller Foundation

University of Michigan–Ann Arbor

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

COMPLICATION AFTER LAPAROSCOPIC DONOR NEPHRECTOMY

Transplantation (1999)

Louis F. Knoepp Mark C. Smith Jarrod Huey Anne T. Mancino H. W. Barber

Background. Laparoscopic procedures are gaining acceptance in the treatment of benign and some malignant urologic disorders. Recently, laparoscopic techniques have been applied to transplant surgery and touted as a safe alternative to traditional open techniques. Methods. We present a patient who developed a complication from laparoscopic donor nephrectomy that required open corrective surgery. Results. A 25-year-old man underwent laparoscopic donor nephrectomy at a large medical center familiar with the operation. There were no operative or early postoperative complications. Within 6 weeks of the operation, the patient developed signs and symptoms of partial small bowel obstruction. Further evaluation revealed an internal hernia in the retroperitoneum at the site of the nephrectomy. This required a second operation to reduce the hernia and close the defect. Conclusion. Laparoscopic donor nephrectomy remains an evolving technique that has not stood the test of time. Larger series will eventually reveal whether this is the procedure of choice as compared to traditional open donor nephrectomy.

10.1097/00007890-199908150-00019

Cite

Citations (50)

Surgery of the Spleen

Humana Press eBooks (2002)

Carol E. H. Scott‐Conner Anne T. Mancino John Lawrence

Laparoscopic splenectomy, nonoperative management of splenic trauma, and the increasing use of partial splenectomy, in cases in which total splenectomy is not obligatory, are among the significant trends in splenic surgery that have emerged since publication of the first edition of this text. As recently as 30 yr ago, splenectomy was routinely performed for even minor splenic injuries. Now the emphasis is on preserving, whenever possible, splenic mass and function by a variety of surgical options.KeywordsThrombotic Thrombocytopenic PurpuraLaparoscopic SplenectomySplenic InjuryAccessory SpleenHereditary SpherocytosisThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

10.1007/978-1-59259-124-4_17

Cite

Citations (0)

Issues in Bilateral Prophylactic Mastectomy

Cancer Practice (2001)

Jennifer Dunn Bucholtz Amy Strauss Tranin Anne T. Mancino Ronda Henry‐Tillman Kent C. Westbrook

10.1111/j.1523-5394.2001.91003.pp.x

Cite

Citations (1)

Can a One-day Workshop Alter Surgeons’ Teaching Practices? 11Presented in part at the 17th Annual Meeting of the Association for Surgical Education, Philadelphia, Pennsylvania, April 9–12, 1997.

The American Journal of Surgery (1998)

Dorothy A. Andriole Stephen R. Evans Hugh M. Foy Robert G. Atnip Anne T. Mancino

Syllabus

Attendance

10.1016/s0002-9610(98)00077-4

Cite

Citations (9)

Contributors

Elsevier eBooks (2009)

Doreen M. Agnese Kathleen G. Allen Raheela Ashfaq Thomas Aversano Sanford H. Barsky

10.1016/b978-1-4160-5221-0.00098-x

Cite

Citations (0)

Flat epithelial atypia on core needle biopsy, must we surgically excise?

The American Journal of Surgery (2016)

Alison A. Acott Anne T. Mancino

Concomitant

Atypia

Lobular carcinoma

10.1016/j.amjsurg.2016.09.019

Cite

Citations (23)

Management of Differentiated Thyroid Cancer

Springer eBooks (2017)

Anne T. Mancino Lawrence T. Kim

10.1007/978-3-319-54493-9

Cite

Citations (4)

Persistent Left Superior Vena Cava

Journal of the Association for Vascular Access (2014)

Vicki L. Mabry Anne T. Mancino Sheila Cox Sullivan

Abstract This is a case report of an incidental diagnosis of persistent left superior vena cava (PLSVC). The diagnosis was suspected after a peripherally inserted central catheter (PICC) was placed and a postinsertion chest radiograph was conducted. PLSVC is a vascular anomaly that is usually diagnosed as an incidental finding. Here, we discuss the tests performed to confirm the diagnosis and the 3 variants of PLSVC. Nurses who place PICCs are likely to run across this abnormality on postinsertion chest radiograph and knowing the diagnostic test to order to confirm the diagnosis is key in expediting patient care.

Chest radiograph

Abnormality

10.1016/j.java.2014.04.001

Cite

Citations (2)

Clinical Evaluation of the Efficacy of a Barrier Cream Containing Polyvinylpyrrolidone in Chronic Hand Eczema

European Journal of Inflammation (2008)

Ga Vena Nicoletta Cassano Michelangelo Vestita Gabriele Alessandrini C. Calvi

The management of chronic hand eczema is usually difficult. The aim of this open-label study is to assess the effectiveness and ‘steroid-sparing’ activity of a barrier cream containing polyvinylpyrrolidone in patients with chronic hand eczema. Rescue treatment with topical corticosteroids (TCs) was permitted in the event of eczema worsening, whereas preventive measures were maintained unchanged with respect to those adopted by patients in the past. Among the 207 participants, the main diagnosis was irritant contact dermatitis, followed by allergic contact dermatitis and atopic dermatitis. Nearly half of the patients (49%) applied the barrier cream once or twice a day, while the remaining patients used it three or more times per day. Regardless of rescue therapy with TCs, regular use of the barrier cream caused a progressive significant improvement of eczema severity, as indicated by dermatologists' and patients' assessments. A significant reduction in the amount of the TC applied in the last 3 months and in the number of TC treatment days during the previous 4 weeks was found at the end of 12-week treatment with the barrier cream as compared with baseline. The product was also well-tolerated and accepted by the majority of patients. The results of this study suggest that a barrier cream containing polyvinylpyrrolidone can represent a useful tool in the management of chronic hand eczema and may show steroid-sparing effects.

Skin Barrier

Polyvinylpyrrolidone

Hand eczema

Hand dermatitis

Atopy

10.1177/1721727x0800600305

Cite

Citations (0)

Injection of Cryopreserved Amniotic Membrane and Umbilical Cord Particulate for Pressure Injuries: A Retrospective Case Series

WOUNDS A Compendium of Clinical Research and Practice (2022)

Anne T. Mancino Alison A. Acott Kathryn P Brinegar

PI poses a significant burden to society. Cryopreserved AMUC has potential benefits in managing complex wounds owing to its anti-inflammatory, anti-scarring, and proregenerative properties. AMUC grafts are commonly in sheets, but also come as morselized powders that can be sprinkled or injected. The authors initially used AMUC injection in chronic PIs in March 2017.This is a single-center, retrospective review of patients with nonhealing PIs treated with AMUC particulate between March 2017 and November 2018. Incidence of wound healing (zero wound volume with complete reepithelialization) was measured at 12, 24, 36, and 52 weeks.Review included 26 PIs (21 patients); of which, 85% were stage 4 PIs, per the NPIAP staging system. After AMUC injection, 14 PIs (54%) achieved complete wound closure at a median of 12.4 weeks (range, 5-52 weeks). Complete wound closure was observed in 7 patients (27%) at 12 weeks, 10 patients (38%) at 24 weeks, 13 patients (50%) at 36 weeks, and 14 patients (54%) at 52 weeks. One patient with vascular issues required amputation; however, no treatment-related adverse events or complications were observed.These preliminary results suggest that injection of AMUC particulate may be a safe and promising treatment in promoting wound closure of difficult-to-treat PIs.

Negative-pressure wound therapy

10.25270/wnds/21041

Cite

Citations (1)